Press release
Genotyping Assays Market Size is Estimated to Worth USD 285.3 Billion by 2034 | TMR Research
Genotyping Assays Market
Genotyping Assays Market is expected to grow at a CAGR of 22.5% from 2024 to 2034 and reach US$ 285.3 Bn by the end of 2034
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54549
Overview of the Genotyping Assays Market
Genotyping assays are used to identify differences in the genetic make-up of an individual by examining the DNA sequence. These assays play a crucial role in various applications, including disease diagnosis, pharmacogenomics, and genetic research. The market includes a range of technologies such as PCR, sequencing, microarrays, and mass spectrometry.
Recent Developments in the Genotyping Assays Market
Recent advancements in the Genotyping Assays market include innovations in assay technologies, improved accuracy and speed of genotyping, and regulatory approvals for new applications. These developments are enhancing the capabilities of genotyping assays and expanding their use in clinical and research settings.
Key Developments:
Next-Generation Sequencing (NGS): The adoption of NGS technologies has revolutionized genotyping by providing high-throughput, accurate, and cost-effective solutions.
CRISPR-Cas9: The integration of CRISPR-Cas9 technology in genotyping assays for precise gene editing and variant detection.
Single-Cell Genotyping: Advances in single-cell genotyping technologies allow for the analysis of genetic variability at the single-cell level, offering deeper insights into genetic disorders.
Regulatory Approvals: Increased number of regulatory approvals for genotyping assays in clinical diagnostics and personalized medicine, facilitating broader market access.
Key Drivers of the Genotyping Assays Market
Several factors are propelling the growth of the Genotyping Assays market. These include the rising incidence of genetic disorders, increasing investment in genomics research, technological advancements, and supportive government initiatives.
Key Drivers:
Prevalence of Genetic Disorders: The increasing prevalence of genetic disorders and the need for early diagnosis are driving the demand for genotyping assays.
Personalized Medicine: The growing adoption of personalized medicine, which relies on genetic information for tailored treatments, is boosting the market.
Technological Advancements: Innovations in genotyping technologies are enhancing the accuracy, speed, and cost-effectiveness of assays.
Genomics Research: Increasing investment in genomics research by public and private sectors is fueling the development and adoption of genotyping assays.
Government Initiatives: Supportive government initiatives and funding for genetic research and precision medicine are fostering market growth.
Top Companies
Illumina, Inc.
Thermo Fisher Scientific
QIAGEN N.V.
Agilent
Danaher Corporation
Roche
GE HealthCare
Standard BioTools Inc.
PerkinElmer
Eurofins Scientific SE
Bio-Rad Laboratories
Pacific Biosciences of California, Inc.
GENEWIZ, Inc.
Integrated DNA Technologies, Inc.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54549
Future Outlook
The future of the Genotyping Assays market looks promising, with ongoing advancements in genotyping technologies, rising demand for personalized medicine, and supportive regulatory frameworks. Industry stakeholders must focus on innovation, strategic partnerships, and addressing cost and ethical challenges to fully capitalize on market opportunities and address challenges.
Segmentation:
Product & Service
Reagents & Kits
Genotyping Services
Instruments
Sequences & Amplifiers
Analyzers
Bioinformatics
Software
Services
Technology
PCR
Real-time PCR
Digital PCR
Microarrays
Sequencing
NGS
Pyrosequencing
Sanger Sequencing
Capillary Electrophoresis
Amplified Fragment Length Polymorphism
Restricted Fragment Length Polymorphism
Single-Stranded Conformation Polymorphism
MALDI-TOF
Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
Application
Pharmacogenomics
Diagnostic & Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
End-user
Pharmaceutical & Biopharmaceutical Companies
Diagnostic & Research Laboratories
Academic Institutes
Others (Animal and Aquagenetics Companies, etc.)
Region
North America
South America
Europe
Asia Pacific
Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=54549<ype=S
More Trending Report by Transparency Market Research:
Healthcare Automation Market: https://www.globenewswire.com/news-release/2023/06/20/2691540/0/en/Healthcare-Automation-Market-Size-Worth-USD-88-9-Bn-in-2028-Growing-at-a-CAGR-of-8-4-TMR-Study.html
Preeclampsia Diagnostics Market: https://www.globenewswire.com/news-release/2023/06/19/2690615/0/en/Preeclampsia-Diagnostics-Market-Set-to-Reach-USD-2-3-Billion-by-2031-growing-at-a-CAGR-of-3-8-TMR-Report.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genotyping Assays Market Size is Estimated to Worth USD 285.3 Billion by 2034 | TMR Research here
News-ID: 3550706 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Genotyping
Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Genotyping Assay Market Size Growth Forecast: What to Expect by 2025?
In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors…
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Genotyping Market Size By 2025?
The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The…
Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Gen …
How Are the key drivers contributing to the expansion of the genotyping market?
The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers…
Genotyping Assay Market worth $37.1 billion by 2029
The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US)
The global genotyping assay market [https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr], valued at US$17.4 billion in 2023, is forecasted to grow at a robust CAGR of 13.8%, reaching US$19.4 billion in 2024 and an impressive US$37.1 billion by 2029. This growth is driven by…
Genotyping Market Outlook and Major Regions' Development Status
The Genotyping Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Genotyping Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100001166?utm_source=OpenPR&utm_medium=10791
Key Players Analysis:
Hoffmann-La Roche Ltd.
Integrated DNA Technologies, Inc.
QIAGEN
MERCK KGaA
Eurofins Genomics
Thermo Fisher Scientific Inc
BioTek Instruments, Inc.
Xcelris Genomics
TrimGen Corporation
Illumina, Inc.
The report covers key developments in the Genotyping…
Single Nucleotide Polymorphisms Genotyping Market - Unraveling Genetic Codes, Un …
Newark, New Castle, USA - new report, titled Single Nucleotide Polymorphisms Genotyping Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Single Nucleotide Polymorphisms Genotyping market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Single Nucleotide Polymorphisms Genotyping market. The report offers…
